When researching the effects of sulforaphane in mice models of skin cancer, Alyoussef and Taha [111] found that sulforaphane blocked sulfatase-2 activity which, when activated, significantly elevated heparan sulfate proteoglycan concentration in plasma. The gene discussed is SULF2; the disease is skin neoplasm.